Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $119.39M | +14.2% |
| 2024 | $104.55M | +25.2% |
| 2023 | $83.53M | +115.3% |
| 2022 | $38.79M | +56.7% |
| 2021 | $24.76M | +165.7% |
| 2020 | $9.32M | -61.3% |
| 2019 | $24.08M | +125.6% |
| 2018 | $10.68M | +19.9% |
| 2017 | $8.90M | - |